STOCK TITAN

Kyivstar (KYIV) acquires Tabletki.ua in $160M deal to expand digital health

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Kyivstar Group Ltd. has completed the acquisition of 100% of Ukrainian online healthcare marketplace Tabletki.ua for USD 160 million, paid entirely in Ukrainian hryvna in Ukraine. The deal closed concurrently with the signing of the definitive agreement.

Tabletki.ua partners with more than 14,000 pharmacies across Ukraine and facilitated an average of 14 million online bookings per month in 2025. Bookings carried a gross merchandise value of UAH 45 billion (USD 1,056 million) for 2024 and UAH 57.3 billion (USD 1,191 million) for the 12 months ended September 30, 2025.

Based on unaudited management accounts as of September 30, 2025, Tabletki.ua generated EBITDA of USD 24 million and net profit of USD 20 million, implying a price-to-earnings multiple of 8.0x. Kyivstar positions the acquisition as expanding its digital healthcare offering alongside assets such as Helsi and Uklon and describes it as immediately earnings accretive with material synergy potential.

Positive

  • None.

Negative

  • None.

Insights

Kyivstar adds a profitable, scaled e-health marketplace with synergies to its digital ecosystem.

Kyivstar is buying 100% of Tabletki.ua for USD 160 million, paid in hryvna in Ukraine. Tabletki.ua shows substantial scale, with GMV of UAH 45 billion in 2024 and UAH 57.3 billion for the 12 months to September 30, 2025, plus 14 million monthly bookings in 2025.

Unaudited figures indicate EBITDA of USD 24 million and net profit of USD 20 million, implying an 8.0x P/E and 6.7x EV/EBITDA multiple. Management characterizes the deal as immediately earnings accretive with “material synergy potential,” helped by overlaps with Helsi, Uklon and Kyivstar’s telecom customer base.

The strategic fit is framed around expanding digital healthcare and multiplay services in Ukraine, though all Tabletki.ua financials are preliminary and unaudited. Subsequent audited results and integration updates in future Kyivstar filings will clarify how these projected synergies and profitability trends develop.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of February 2026

 

Commission File Number: 001-42804

 

Kyivstar Group Ltd.

(Translation of registrant’s name into English)

 

Unit 517, Level 5

Index Tower

Dubai International Financial Centre (DIFC)

United Arab Emirates

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 

 

 

EXPLANATORY NOTE

 

On February 10, 2026, Kyivstar Group Ltd. (the “Company”) announced the execution of a securities purchase agreement (the “Definitive Agreement”) by and between Private Joint Stock Company Kyivstar, VEON Holdings B.V., and the selling shareholders of Tabletki.ua: Oleksandr Muravshchyk, Nataliia Muravshchyk, Yurii Savchyn, Volodymyr Osmachko, Ievgen Muravshchyk and Vadym Rohatynskyi, dated February 10, 2026, pursuant to which the Company will acquire 100% of the equity interests of Tabletki.ua, a leading Ukrainian online platform for healthcare products that enables consumers to find, compare, and book medicines and other products at Ukrainian pharmacies.

 

The Company acquired Tabletki.ua for aggregate consideration of approximately USD 160 million, paid fully in Ukrainian Hryvna in Ukraine. The transaction closed concurrently with the execution of the Definitive Agreement.

 

EXHIBIT INDEX

 

The following exhibits are furnished as part of this Form 6-K:

 

Exhibit   Description
99.1   Press Release, dated February 10, 2026
99.2   Investor Presentation, dated February 10, 2026

 

1

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: February 10, 2026 Kyivstar Group Ltd.
       
  By: /s/ Boris Dolgushin
    Name:  Boris Dolgushin
    Title: Chief Financial Officer

 

 

 2

 

 

 

Exhibit 99.1

 

 

PRESS RELEASE

 

Kyivstar to Expand Digital Healthcare Offering in Ukraine with Tabletki.ua Acquisition

 

Kyiv, February 10, 2026 - Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW) (“Kyivstar”), Ukraine's leading digital operator and the first Ukrainian company to trade on the Nasdaq, has today signed a definitive agreement and completed the transaction to acquire 100% of Tabletki.ua for a consideration of USD 160 million, which will be paid in full in Ukrainian hryvna in Ukraine. Tabletki.ua is one of Ukraine’s most widely used digital marketplaces for healthcare products that enables consumers to find, compare, and book medicines and other products at Ukrainian pharmacies.

 

Tabletki.ua facilitates customers’ access to medicines and healthcare, as well as nutrition and consumer products, aggregating data on the availability and pricing of medicines, medical devices and more. Tabletki.ua joins Kyivstar’s widening portfolio of digital services, including digital healthcare platform Helsi, ride-hailing and delivery service Uklon, digital media platform Kyivstar TV and the MyKyivstar superapp.

 

“Even in challenging times, Ukrainian businesses like Tabletki.ua are enabling millions of Ukrainians to benefit from convenient, digital-first solutions, supporting the growth and resilience of the country,” said Oleksander Komarov, President of Kyivstar. “Tabletki.ua already plays a vital role in everyday life for millions of Ukrainians This acquisition will allow us to combine Kyivstar’s successful track record of running and growing digital businesses with Tabletki.ua’s solid foundations to expand digital healthcare to a wider customer base and offer more convenience for all.”

 

Tabletki.ua partners with more than 14,000 pharmacies across Ukraine, and facilitated an average of 14 million online bookings per month in 2025, reflecting its role as a trusted, everyday healthcare tool for Ukrainian families. The gross merchandise value (GMV) of bookings facilitated through the platform amounted to UAH 45 billion (USD 1,056 million) for FY2024 and UAH 57.3 billion (USD 1,191 million) for the last 12 months (“LTM”) ending September 30, 2025.

 

Based on unaudited management accounts, Tabletki.ua generated LTM EBITDA of USD 24 million and LTM net profit of USD 20 million as of September 30, 2025. The agreed consideration of USD 160 million corresponds to a price to LTM earnings (PE) ratio of 8.0X.

 

Today, Kyivstar also published a presentation for investors that provides further information about Tabletki.ua and the strategic rationale for the acquisition. The presentation is available on the Kyivstar website here: https://investors.kyivstar.ua/static-files/4695eb4f-e085-4a5e-bad6-f4fc71d51d87

 

About Kyivstar Group Ltd.

 

Kyivstar Group Ltd. (“Kyivstar”) is a Nasdaq-listed holding company that operates JSC Kyivstar, Ukraine’s leading digital operator and the first Ukrainian company to list on a U.S. stock exchange.Kyivstar’s companies provide a broad range of connectivity and digital services, including mobile and fixed-line voice and data, ride-hailing, e-health, digital TV, and enterprise solutions such as Big Data, cloud, and cybersecurity.

 

Together with VEON, Kyivstar intends to invest USD 1 billion in Ukraine between 2023-2027, through investments in infrastructure, technological development and strategic acquisitions, as well as charitable donations for social projects.

 

For more information, please visit https://investors.kyivstar.ua.

 

Nasdaq tickers: KYIV; KYIVW

 

 

 

 

 

About JSC Kyivstar

 

JSC Kyivstar is Ukraine’s leading digital operator, serving more than 22.5 million mobile customers and over 1.2 million home internet fixed line customers as of September 30, 2025. The company provides services using a wide range of mobile and fixed technologies, including 4G, Big Data, cloud solutions, cybersecurity services, digital TV, and more. JSC Kyivstar is advancing new telecommunication technologies in Ukraine and together with VEON plans to invest USD 1 billion in this direction between 2023-2027.

 

JSC Kyivstar is wholly owned by Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW), the first Ukrainian company to have its shares traded on the U.S. stock exchange Nasdaq.

 

The company contributes to overcoming the challenges of wartime and, over the past three years, has allocated over UAH 3.4 billion to support the Defense Forces, its subscribers, and the implementation of social projects. JSC Kyivstar has operated in Ukraine for 27 years and is recognized as the largest taxpayer in the digital communications market, a top employer, and a socially responsible company.

 

Additional information: pr@kyivstar.net, www.kyivstar.ua.

 

Disclaimer

 

This press release contains “forward-looking statements,” as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements relating to, among other things, the closing of Kyivstar’s acquisition of Tabletki.ua, the expected impact of the acquisition for Kyivstar Group and the expected financial performance of Kyivstar Group post the acquisition. There are numerous risks and uncertainties that could cause actual results and performance to differ materially from those expressed by such statements, including risks relating to the closing of Kyivstar’s acquisition of Tabletki.ua, the expected impact of the acquisition for Kyivstar Group, the expected financial performance of Kyivstar Group post the acquisition, as well as Kyivstar’s ability to achieve anticipated results and business objectives, among others discussed in the section entitled “Risk Factors” included in the final prospectus filed by Kyivstar with the U.S. Securities and exchange Commission (“SEC”) on January 30 , 2025, as amended and supplemented from time to time, and in any other subsequent filings with the SEC by Kyivstar. Kyivstar disclaims any obligation to update or revise any forward-loooking statements contained in this press release, other than to the extent required by applicable law.

 

Additionally, this press release includes certain financial information and data of Tabletki. derived from preliminary, unaudited management accounts as of the dates indicated and is subject to completion of customary financial closing, review, and audit procedures. This information is provided for informational purposes only and should not be regarded as a complete statement of financial results or relied upon as necessarily indicative of historical or future performance.

 

 

 

 

 

Exhibit 99.2

 

Kyivstar Group Ltd. February 10, 2026 | Investor Presentation (1) Gross Merchandise Value Tabletki.ua Acquisition: Advancing Kyivstar’s Digital Ecosystem ▪ >USD 1 Billion+ GMV 1 ▪ Material Synergy Potential

 

 

DISCLAIMER 2 This presentation includes certain historical financial information and data relating to Tabletki . ua relating to periods prior to its acquisition by Kyivstar Group . Such information is unaudited, was prepared by Tabletki . ua prior to the acquisition, and has not been reviewed or audited by Kyivstar Group's independent registered public accounting firm . The unaudited financial information is subject to further review, revision and transaction - related accounting and other adjustments, and may be revised, potentially materially, and is therefore being provided for informational purposes only . Accordingly, this information may not be indicative of final historical results or future performance . This presentation includes certain financial and operating measures of Tabletki . ua, including EBITDA and EBITDA margin, that are not prepared in accordance with U . S . generally accepted accounting principles (“GAAP”) or International Financial Reporting Standards (“IFRS”) . These non - GAAP/non - IFRS measures, and other measures that are calculated using these non - GAAP/non - IFRS measures, are in addition to, and not a substitute for or superior to measures of financial performance prepared in accordance with GAAP or IFRS and should not be considered as an alternative or substitute to those determined in accordance with GAAP or IFRS . The Company believes these non - GAAP/non - IFRS financial measures provide valuable insights into key financial and business trends, offering management and potential investors a useful tool for evaluating Tabletki . ua ’s historical performance and comparing it with peers that report similar metrics . These non - GAAP/non - IFRS measures have limitations, including potential differences in definition from those used by other companies, which may affect comparability . This presentation contains “forward - looking statements”, within the meaning of Section 27 A of the U . S . Securities Act of 1933 , as amended, and Section 21 E of the U . S . Securities Exchange Act of 1934 , as amended . All statements contained in this presentation that do not relate to historical fact should be considered forward - looking statements including, without limitation, statements relating to, among other things, the proposed acquisition of Tabletki . ua, the expected impact of the acquisition for Kyivstar Group, the expected financial performance of Kyivstar Group post the acquisition as well as Kyivstar Group’s ability to achieve anticipated results and business objectives and its strategic plans . These statements are based on management’s current expectations and are neither promises nor guarantees . There are numerous risks and uncertainties that could cause actual results and performance to differ materially from those expressed by such statements, including risks relating to uncertainty over Kyivstar Group’s’ ability to achieve anticipated results and business objectives, among others discussed in the section entitled “Risk Factors” included in the final prospectus filed by Kyivstar Group with the U . S . Securities and exchange Commission (“SEC”) on January 30 , 2026 , as such document may be amended or supplemented from time to time and in any other subsequent filings with the SEC by Kyivstar Group . You are cautioned not to place undue reliance on these forward - looking statements . The forward - looking statements speak only as of the date hereof and we disclaim any obligation to update them, except to the extent required by law . Kyivstar disclaims any obligation to update or revise any forward - looking statements contained in this press release, other than to the extent required by applicable law . This presentation is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction .

 

 

Maintain paying subscriber base and grow share of multiplay users Technology (e.g., Direct to Cell) and value - driven, consistent ARPU growth Fixed broadband market share growth via organic expansion and acquisitions Sustain mobile market leadership GROWTH STRATEGY AND PRIORITIES 3 Telecom Digital Grow digital offerings organically and through adjacent acquisitions by focusing on increasing multiplay penetration Target significant organic growth in digital revenues, complemented by acquisitions Serve as a key player in restoring and developing Ukraine’s digital ecosystem Leverage our loyal customer base to launch and develop new and existing digital products

 

 

EXECUTING TO OUR STRATEGY Increased ownership in Helsi from 69.99% to 97.99% Announced acquisition of 97% stake in Uklon Launched Starlink Direct to Cell Satellite Connectivity in Ukraine Nov 2024 Mar 2025 May 2025 Nov 2025 Announced acquisition of Tabletki.ua, to further expand digital healthcare offering Feb 2026 Acquired valuable new spectrum in an auction to support mobile network capacity and coverage Announced acquisition of SUNVIN 11 LLC, owner of an operational solar plant with 12.95 MW capacity Dec 2025 4

 

 

TABLETKI.UA – AN OVERVIEW Business Overview Leading marketplace: for searching and online booking of medicines in Ukraine (via web portal and mobile app) Rich history: Established in 2008. Have built deep consumer trust, strong pharmacy partnerships, and a resilient market position Extensive reach: 14,000+ connected pharmacies, serving all Ukrainian cities with populations exceeding 50,000 High user engagement: Averaged 14 million online bookings/month 1 in 2025 85.0% 12.2% 2.8% Transactions and subscription fees Advertising Other Business Model Revenue drivers: Transaction fees, pharmacy subscriptions, and advertising revenues Strong growth: Gross merchandise value (GMV) of bookings facilitated at UAH 45 billion for 2024 and UAH 57.3 billion for LTM 9M2025 Strong profit growth: Preliminary EBITDA CAGR: 69% over 2021 - 2024 1 . Robust EBITDA margin trend 1 Talented team: Deep experience in developing and implementing pharmacy automation systems and software (1) The financial information and data presented herein is derived from preliminary, unaudited management accounts prepared by Tabletki.ua as of the dates indicated and is subject to completion of customary financial closing procedures, review, and audit. Certain amounts and percentages may reflect rounding adjustments and may not recalculate exactly. While this information has been prepared on a basis believed to be reasonable, it remains subject to revision and may change materially due to final adjustments, audit processes, transaction accounting determinations, and other adjustments. Accordingly, actual results for historical and future periods may differ from the preliminary information presented, and such differences may be material. This information is provided for informational purposes only and should not be regarded as a complete statement of financial results or relied upon as necessarily indicative of historical or future performance. Preliminary Financials 1 USD UAH mn LTM 9M25 9M25 2024 LTM 9M25 9M25 2024 1,191 1,034 1,056 57,300 43,000 45,000 GMV 24.0 18 20 1,000 755 810 EBITDA 2 29.0 69.4 34.0 86.0 Growth YoY (Sep - Sep, %) 20.0 16.0 17.6 836 682 707 Net Profit Revenue Distribution (2024) 1 5 (2) EBITDA is a historical, non - IFRS measure provided by Tabletki.ua from unaudited management accounts for the periods indicated. A reconciliation to their most directly comparable GAAP or IFRS measures is not provided because such quantitative reconciliation is not available without unreasonable efforts. Kyivstar Group is unable to assess the probable significance of the unavailable information and the quantification of these items would require significant estimates and judgments and could be material and unpredictable in amount or timing.

 

 

ACQUISITION TERMS AND ANTICIPATED SYNERGIES Implied Valuation (as of 9M25) EV / EBITDA P/E 6.7x 8.0x LTM 2 LTM 3 Acquisition Terms Purchase Price USD 160 million 1 Terms Consideration being fully paid in UAH in Ukraine 1 Enrich with Mobile Data Mobile data enrichment to improve user engagement and accessibility Potential Synergies Digital Health Ecosystem Development Fully aligned with Digital Operator strategy; substantial catalyst for development of Digital Health ecosystem Fuels Digital Flywheel Momentum High - frequency service to further boost user engagement across the digital ecosystem Kyivstar Ecosystem Synergies Synergies between Kyivstar (telco), Helsi (largest eHealth SaaS provider), Uklon (delivery) and Tabletki.ua (leading medicine marketplace) to drive substantial customer benefits. 6 Immediately Earnings Accretive with Material Synergy Potential (1) Consideration in UAH, based on UAH/USD exchange rate as published by the Central Bank of Ukraine from the day before payment (2) USD 160mn / USD 24mn (3) USD 160mn / USD 20mn

 

 

ir@kyivstargroup.com

 

FAQ

What did Kyivstar Group Ltd. (KYIV) acquire in the Tabletki.ua deal?

Kyivstar acquired 100% of Tabletki.ua, a leading Ukrainian online marketplace for medicines and healthcare products. The platform lets users search, compare and book items at pharmacies, complementing Kyivstar’s existing digital services such as Helsi, Uklon, Kyivstar TV, and the MyKyivstar superapp.

How much did Kyivstar (KYIV) pay for Tabletki.ua and how was it funded?

Kyivstar agreed to pay USD 160 million to acquire Tabletki.ua, with the consideration paid fully in Ukrainian hryvna in Ukraine. The valuation implies an 8.0x price-to-earnings multiple based on unaudited net profit of USD 20 million as of September 30, 2025.

How big is Tabletki.ua’s business based on recent activity?

Tabletki.ua facilitated GMV of UAH 45 billion (USD 1,056 million) in 2024 and UAH 57.3 billion (USD 1,191 million) for the 12 months ending September 30, 2025. It averaged about 14 million online bookings per month during 2025, partnering with more than 14,000 pharmacies across Ukraine.

Is the Tabletki.ua acquisition immediately earnings accretive for Kyivstar?

Kyivstar describes the Tabletki.ua acquisition as immediately earnings accretive with material synergy potential. Tabletki.ua reported unaudited EBITDA of USD 24 million and net profit of USD 20 million as of September 30, 2025, supporting this view, though all figures are preliminary and unaudited.

What profitability metrics does Tabletki.ua contribute to Kyivstar (KYIV)?

Based on unaudited management accounts, Tabletki.ua generated EBITDA of USD 24 million and net profit of USD 20 million as of September 30, 2025. These figures underpin an implied 6.7x EV/EBITDA and 8.0x price-to-earnings multiple at the USD 160 million purchase price.

How does Tabletki.ua fit into Kyivstar’s wider digital strategy in Ukraine?

Tabletki.ua strengthens Kyivstar’s digital healthcare ecosystem alongside Helsi and other platforms. Kyivstar’s strategy emphasizes multiplay digital services, and management highlights potential synergies between telecom connectivity, Helsi’s e-health SaaS, Uklon’s delivery capabilities, and Tabletki.ua’s medicine marketplace across Ukraine.

Filing Exhibits & Attachments

10 documents
Kyivstar Group Ltd

NASDAQ:KYIV

KYIV Rankings

KYIV Latest News

KYIV Latest SEC Filings

KYIV Stock Data

2.75B
30.81M
Telecom Services
Communication Services
Link
United Arab Emirates
Dubai